Early career researchers have an essential role to play in the move towards open research, says #SciData17 writing competition winner Sarah Lemprière.
Five things you can do today to make tomorrow’s research open
1
Tag Archives: ecrs
Abandon ship, or learn to swim: the gamble young scientists must make
For scientists, there’s nothing more frightening than a major grant rejection. With the scarcity of funding at the forefront of everyone’s thoughts, it’s time to talk about options, says Atma Ivancevic.
Job stability and a career in research are rarely put together. Science is a windy, grueling, uphill climb that might end abruptly at the edge of a cliff. Halloween is a particularly scary time for Australian scientists, as it signals the release of #NHMRC project grant results. Right now, many laboratories are facing difficult decisions due to rejected funding for next year. It’s not a surprise — we see it everywhere — yet it’s a shock that affects the entire scientific community. For early career researchers across the globe, it’s a timely reminder to carefully consider and plan for the future.
So, what are your options?
The competition that likes to say YES!
Enterprising early career researchers get some high-level mentoring to handle the rough and tumble of the boardroom. David Payne meets finalists in the 21st annual Young Entrepreneurs Scheme (YES)
Epitome is a Singapore biotech start-up whose product pipeline is based on engineered tail proteins to tackle bacterial diseases. It wants a slice of the US’s $6bn acne market. Epitome’s founders are seeking raise $10m to build a factory where its cosmetic products can be manufactured. Investors will be rewarded with a seat on its board.
The launch team describe the company at a presentation attended by other young entrepreneurs. They brace themselves for some tough questions from a judging panel. One judge asks how a factory can be built for $10m Another challenges the team’s plan to launch an acne treatment as a cosmetic product, which means they won’t mention acne on the label (the team adopted this approach to make the US regulatory process more straightforward).
Elena Lurieluke, Head of Global Life Sciences Open Innovation, Corporate R&D at P&G, addresses fellow YES judges and finalists.